-+ 0.00%
-+ 0.00%
-+ 0.00%

TRANSCODE THERAPEUTICS - TO EVALUATE STRATEGIC ALTERNATIVES INCLUDING LICENSING AND PARTNERSHIPS

Reuters·10/28/2026 20:41:07